Insights

Innovative blood testing Babson Diagnostics’ BetterWay offers needle-free, fingertip capillary blood collection for routine testing, presenting a compelling healthcare accessibility angle for hospitals, clinics, and retailers seeking patient-friendly lab services.

Strategic partnerships Recent collaboration with BD for the BD MiniDraw Capillary Blood Collection System, plus ongoing lab testing capabilities, opens opportunities with large diagnostics manufacturers and supply chain partners seeking integrated capillary testing workflows.

Recognition and credibility Industry accolades (Medtech Company of the Year, SXSW Innovation Award, Fast Company Most Innovative Companies) bolster credibility when approaching health systems, payers, and distributors for rapid adoption and co-branding opportunities.

Retail expansion Launch of GLP-1 testing panels at Texas retail locations indicates a channel expansion strategy to non-traditional settings; sales teams should target pharmacy chains, big-box retailers, and direct-to-consumer channels seeking convenient, on-site blood testing options.

Scale-ready operations With revenue in the mid-range and a growing customer base, there is potential to upsell automated preanalytical solutions, data analytics, and telehealth ecosystem integrations to improve lab throughput, reduce errors, and enhance patient engagement for large clinics and mid-sized health systems.

Similar companies to Babson Diagnostics

Babson Diagnostics Tech Stack

Babson Diagnostics uses 8 technology products and services including Google AdSense, The Trade Desk, Snowplow, and more. Explore Babson Diagnostics's tech stack below.

Media & News

Babson Diagnostics's Email Address Formats

Babson Diagnostics uses at least 2 email formats:
Babson Diagnostics Email FormatsExamplePercentage
First.Last@babsondx.comJohn.Doe@babsondx.com
100%
First@betterway.comJohn@betterway.com
100%

Frequently Asked Questions

What is Babson Diagnostics's official website and social media links?

Minus sign iconPlus sign icon
Babson Diagnostics's official website is betterway.com and has social profiles on LinkedIn.

How much revenue does Babson Diagnostics generate?

Minus sign iconPlus sign icon
As of October 2026, Babson Diagnostics's annual revenue is estimated to be $25M - $50M.

What is Babson Diagnostics's NAICS code?

Minus sign iconPlus sign icon
Babson Diagnostics's NAICS code is 6215 - Medical and Diagnostic Laboratories.

How many employees does Babson Diagnostics have currently?

Minus sign iconPlus sign icon
As of October 2026, Babson Diagnostics has approximately 54 employees across 3 continents, including North America, Africa and Europe. Key team members include Digital Marketing Director: A. H., Director, Quality Assurance & Regulatory Affairs: J. H. and Director Of Accounting: K. S. Explore Babson Diagnostics's employee directory with LeadIQ.

What industry does Babson Diagnostics belong to?

Minus sign iconPlus sign icon
Babson Diagnostics operates in the Medical and Diagnostic Laboratories industry.

What technology does Babson Diagnostics use?

Minus sign iconPlus sign icon
Babson Diagnostics's tech stack includes Google AdSense, The Trade Desk, Snowplow, Amazon Web Services, WordPress, CookieYes, Mailchimp and Microsoft 365.

What is Babson Diagnostics's email format?

Minus sign iconPlus sign icon
Babson Diagnostics's email format typically follows the pattern of First.Last@babsondx.com. Find more Babson Diagnostics email formats with LeadIQ.

How much funding has Babson Diagnostics raised to date?

Minus sign iconPlus sign icon
As of October 2026, Babson Diagnostics has raised $45M in funding. The last funding round occurred on Oct 08, 2024.

When was Babson Diagnostics founded?

Minus sign iconPlus sign icon
Babson Diagnostics was founded in 2017.
Babson Diagnostics logo

Babson Diagnostics

Medical and Diagnostic LaboratoriesTexas, United States51-200 Employees

Babson Diagnostics is a healthcare technology company that focuses on blood testing using capillary collection, aiming to deliver accurate lab results without traditional phlebotomy. The BetterWay service, developed by Babson, is positioned to reduce patient anxiety and inconvenience associated with blood draws, potentially improving testing adherence and health equity by enabling fingertip blood sampling. The company operates in the medical and diagnostic laboratories sector and has established its base in Austin, Texas, with a workforce described in the mid-sized range. In addition to its core testing approach, Babson has pursued recognition through industry awards and public announcements, including leadership changes and new testing panels rolled out at retail locations, which illustrate continued expansion of its testing capabilities. Overall, Babson sits at the intersection of clinical diagnostics and patient-centered care, seeking to shift routine testing away from traditional venipuncture toward more accessible, scalable blood testing options. }

Section iconCompany Overview

NAICS Code
6215 - Medical and Diagnostic Laboratories
Founded
2017
Employees
51-200

Section iconFunding & Financials

  • $45M

    Babson Diagnostics has raised a total of $45M of funding over 3 rounds. Their latest funding round was raised on Oct 08, 2024 as a Corporate Round.

  • $25M - $50M

    Babson Diagnostics's revenue is estimated to be in the range of $25M - $50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.